Fonseca R, Bergsagel PL, Drach J, Shaughnessy J, Gutierrez N, Stewart AK, et al. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia. 2009;23:2210–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Munshi NC, Avet-Loiseau H. Genomics in multiple myeloma. Clin Cancer Res. 2011;17:1234–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bolli N, Avet-Loiseau H, Wedge DC, Van Loo P, Alexandrov LB, Martincorena I, et al. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat Commun. 2014;5:2997.

Article  PubMed  Google Scholar 

Kazandjian D. Multiple myeloma epidemiology and survival: A unique malignancy. Semin Oncol. 2016;43:676–81.

Article  PubMed  PubMed Central  Google Scholar 

Kumar SK, Rajkumar SV. The multiple myelomas - current concepts in cytogenetic classification and therapy. Nat Rev Clin Oncol. 2018;15:409–21.

Article  CAS  PubMed  Google Scholar 

Hoang PH, Cornish AJ, Dobbins SE, Kaiser M, Houlston RS. Mutational processes contribute to the development of multiple myeloma. Blood Cancer J. 2019;9:60.

Article  PubMed  PubMed Central  Google Scholar 

Chesi M, Nardini E, Brents LA, Schröck E, Ried T, Kuehl WM, et al. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet. 1997;16:260–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Walker BA, Mavrommatis K, Wardell CP, Ashby TC, Bauer M, Davies FE, et al. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma. Blood. 2018;132:587–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ziccheddu B, Da Via MC, Lionetti M, Maeda A, Morlupi S, Dugo M, et al. Functional Impact of Genomic Complexity on the Transcriptome of Multiple Myeloma. Clin Cancer Res. 2021;27:6479–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Palumbo A, Avet-Loiseau H, Oliva S, Lokhorst HM, Goldschmidt H, Rosinol L, et al. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group. J Clin Oncol. 2015;33:2863–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kumar S, Kaufman JL, Gasparetto C, Mikhael J, Vij R, Pegourie B, et al. Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma. Blood. 2017;130:2401–9.

Article  CAS  PubMed  Google Scholar 

Takamatsu H, Yamashita T, Kurahashi S, Saitoh T, Kondo T, Maeda T, et al. Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation. Biol Blood Marrow Transplant. 2019;25:474–9.

Article  CAS  PubMed  Google Scholar 

Paner A, Patel P, Dhakal B. The evolving role of translocation t(11;14) in the biology, prognosis, and management of multiple myeloma. Blood Rev. 2020;41:100643.

Article  CAS  PubMed  Google Scholar 

Lonial S, Dimopoulos M, Palumbo A, White D, Grosicki S, Spicka I, et al. Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma. N Engl J Med. 2015;373:621–31.

Article  CAS  PubMed  Google Scholar 

Dimopoulos MA, Dytfeld D, Grosicki S, Moreau P, Takezako N, Hori M, et al. Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma. N Engl J Med. 2018;379:1811–22.

Article  CAS  PubMed  Google Scholar 

Giri S, Grimshaw A, Bal S, Godby K, Kharel P, Djulbegovic B, et al. Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients With High-risk Cytogenetic Factors: A Systematic Review and Meta-analysis. JAMA Oncol. 2020;6:1759–65.

Article  PubMed  Google Scholar 

Usmani SZ, Quach H, Mateos MV, Landgren O, Leleu X, Siegel D, et al. Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): updated outcomes from a randomised, multicentre, open-label, phase 3 study. Lancet Oncol. 2022;23:65–76.

Article  CAS  PubMed  Google Scholar 

Taniwaki M, Nishida K, Ueda Y, Misawa S, Nagai M, Tagawa S, et al. Interphase and metaphase detection of the breakpoint of 14q32 translocations in B-cell malignancies by double-color fluorescence in situ hybridization. Blood. 1995;85:3223–8.

Article  CAS  PubMed  Google Scholar 

Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538–548.

Article  PubMed  Google Scholar 

Mizuno Y, Chinen Y, Tsukamoto T, Takimoto-Shimomura T, Matsumura-Kimoto Y, Fujibayashi Y, et al. A novel method of amplified fluorescent in situ hybridization for detection of chromosomal microdeletions in B cell lymphoma. Int J Hematol. 2019;109:593–602.

Article  CAS  PubMed  Google Scholar 

Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.

Article  CAS  PubMed  Google Scholar 

Otsuki T, Wada H, Nakazawa N, Taniwaki M, Kouguchi K, Ohkura M, et al. Establishment of CD7+ human myeloma sister cell lines, KMS-21-PE and KMS-21-BM, carrying t(11;14) and t(8;14). Leuk Lymphoma. 2001;42:761–74.

Article  CAS  PubMed  Google Scholar 

Lombardi L, Poretti G, Mattioli M, Fabris S, Agnelli L, Bicciato S, et al. Molecular characteriation of human multiple myeloma cell lines by integrative genomics: insights into the biology of the disease. Genes Chromosomes Cancer. 2007;46:226–38.

Article  CAS  PubMed  Google Scholar 

Gray JW, Carrano AV, Steinmetz LL, Van Dilla MA, Moore DH, Mayall BH, et al. Chromosome measurement and sorting by flow systems. Proc Natl Acad Sci USA. 1975;72:1231–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stanley J, Hui H, Erber W, Clynick B, Fuller K. Analysis of human chromosomes by imaging flow cytometry. Cytom B. 2021;100:541–53.

Article  Google Scholar 

Maguire O, Wallace PK, Minderman H. Fluorescent In Situ Hybridization in Suspension by Imaging Flow Cytometry. Methods Mol Biol. 2016;1389:111–26.

Article  PubMed  PubMed Central  Google Scholar 

Fuller KA, Bennett S, Hui H, Chakera A, Erber WN. Development of a robust immuno-S-FISH protocol using imaging flow cytometry. Cytom A. 2016;89:720–30.

Article  CAS  Google Scholar 

Grimwade LF, Fuller KA, Erber WN. Applications of imaging flow cytometry in the diagnostic assessment of acute leukaemia. Methods. 2017;112:39–45.

Article  CAS  PubMed  Google Scholar 

Hui HYL, Clarke KM, Fuller KA, Stanley J, Chuah HH, Ng TF, et al. “Immuno-flowFISH” for the Assessment of Cytogenetic Abnormalities in Chronic Lymphocytic Leukemia. Cytom A. 2019;95:521–33.

Article  CAS  Google Scholar 

Zahedipour F, Ranjbaran R, Behzad Behbahani A, Afshari KT, Okhovat MA, Tamadon G, et al. Development of Flow Cytometry-Fluorescent In Situ Hybridization (Flow-FISH) Method for Detection of PML/RARa Chromosomal Translocation in Acute Promyelocytic Leukemia Cell Line. Avicenna J Med Biotechnol. 2017;9:104–8.

PubMed  PubMed Central  Google Scholar 

Hui HYL, Stanley J, Clarke K, Erber WN, Fuller KA. Multi-probe FISH Analysis of Immunophenotyped Chronic Lymphocytic Leukemia by Imaging Flow Cytometry. Curr Protoc. 2021;1:e260.

Article  CAS  PubMed  Google Scholar 

Bennour A, Saad A, Sennana H. Chronic myeloid leukemia: Relevance of cytogenetic and molecular assays. Crit Rev Oncol Hematol. 2016;97:263–74.

Article  PubMed  Google Scholar 

Ma ES. Recurrent Cytogenetic Abnormalities in Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia. Methods Mol Biol. 2017;1541:279–93.

Article  CAS  PubMed  Google Scholar 

Novo M, Castellino A, Nicolosi M, Santambrogio E, Vassallo F, Chiappella A, et al. High-grade B-cell lymphoma: how to diagnose and treat. Exp Rev Hematol. 2019;12:497–506.

Article  CAS  Google Scholar 

Witzig TE, Kimlinger T, Stenson M, Therneau T. Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemia. Leuk Lymphoma. 1998;31:167–75.

Article  CAS  PubMed  Google Scholar 

Kovarova L, Buresova I, Buchler T, SUSKA R, POUR L, ZAHRADOVA L, et al. Phenotype of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance. Neoplasma. 2009;56:526–32.

Article  CAS  PubMed